Company: NDRA
Filing Date: 2025-10-30
Form Type: 424B5
Source: 0001213900-25-103705
Chunk: 42

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-30
Form: 424B5
Chunk 42
---
S                                                                                         |   25 |
| WHERE YOU CAN FIND MORE INFORMATION                                                             |   25 |
| INCORPORATION BY REFERENCE                                                                      |   26 |

<div align='center'>i

ABOUT THIS PROSPECTUS</div>

This prospectus is part of a registration statement
on Form S-3 that we filed with the Securities and Exchange Commission, or the SEC, utilizing a “shelf’ registration process.
Under this shelf process, we may from time to time sell any combination of securities described in this prospectus in one or more offerings.

This prospectus provides you with a general description
of the securities we may offer. Each time we sell securities under this shelf registration process, we will provide a prospectus supplement
that will contain specific information about the terms of the securities being offered. That prospectus supplement may include a discussion
of any risk factors or other special consideration that apply to those securities. The prospectus supplement may also add, update or change
information contained in this prospectus. If there is any inconsistency between the information in this prospectus and a prospectus supplement,
you should rely on the information in that prospectus supplement. You should read both this prospectus and any applicable prospectus supplement
together with additional information described below under the headings “Where You Can Find More Information” and “Incorporation
by Reference.”

When acquiring any securities discussed in this
prospectus, you should rely on the information provided in this prospectus and the prospectus supplement, including the information incorporated
by reference. Neither we, nor any underwriters or agents, have authorized anyone to provide you with different information. We are not
offering the securities in any state where such an offer is prohibited. You should not assume that the information in this prospectus,
any prospectus supplement, or any document incorporated by reference, is truthful or complete at any date other than the date mentioned
on the cover page of those documents. You should also carefully review the section entitled “Risk Factors”, which highlights
certain risks associated with an investment in our securities, to determine whether an investment in our securities is appropriate for
you.

Unless otherwise stated or the context requires
otherwise, references to “ENDRA”, the “Company,” “we,” “us” or “our” are to
ENDRA Life Sciences Inc. and its subsidiaries.

<div align='center'>1

FORWARD-LOOKING
STATEMENTS</div>

Certain information set forth in this prospectus
or incorporated by